Characterization and quantification of genotoxic impurities complying with ICH M7: A pharma perspective
Landolfi, C., Devastato, C., Corradin, M., Durando, L., Ombrato, R., Silvestri, L., Pavan, M., Fioravanzo, E., Tongiani, S.
Published in Toxicology letters (01.10.2015)
Published in Toxicology letters (01.10.2015)
Get full text
Journal Article
P.2.d.032 Glycogen synthase kinase 3 (GSK-3β) an emerging target for neurological disease: in silico study to investigate the binding mode of trazodone
Ombrato, R, Alisi, M.A, Cazzolla, N, Corso, G, Manelfi, C, Mangano, G, Magnani, M, Milanese, C, Olivieri, L, Polenzani, L
Published in European neuropsychopharmacology (2009)
Published in European neuropsychopharmacology (2009)
Get full text
Journal Article
In silico assessment of genotoxic impurities: Case-studies using ChemTunes Studio
Fioravanzo, E., Yang, C., Rathman, J.F., Schwab, C.H., Kovarich, S., Ombrato, R., Silvestri, L.
Published in Toxicology letters (16.10.2015)
Published in Toxicology letters (16.10.2015)
Get full text
Journal Article
Risk assessment and control of potentially genotoxic impurities: Implementation of a fully integrated approach
Devastato, C., Fioravanzo, E., Kovarich, S., Pavan, M., Schwab, C., Ombrato, R., Corradin, M., Silvestri, L., Yang, C.
Published in Toxicology letters (16.09.2016)
Published in Toxicology letters (16.09.2016)
Get full text
Journal Article